UNSPSC 85877026: Fluoroscopy of right lower leg

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of right lower leg. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code BQ1DZZZ

UNSPSC 85877026 Fluoroscopy of right lower leg is a Commodity code that shows significant mismatch between its nominal scope and recent state and local procurement activity tagged under it. The three recent opportunities posted under this code involve diagnostic imaging systems implementation (a PACS platform), ultrasound equipment procurement, and phlebotomy services — none of which align with fluoroscopy of a specific lower-extremity anatomical location. The code appears to capture clinical diagnostic and specimen-collection services more broadly than its name suggests, though the tagging may reflect indexing imprecision rather than genuine scope expansion. Issuing bodies include a county-level public health system (San Mateo Medical Center), a county government procurement office (Collier County, Florida), and a municipal police department (Albuquerque Police Department), indicating activity across public health, county procurement, and law enforcement contexts.

Geographic activity spans California, Florida, and New Mexico based on the three recent solicitations. San Mateo Medical Center posted an RFP for Diagnostic Imaging PACS due August 7, 2026, seeking enterprise-grade system implementation with EPIC Electronic Health Record integration, 99.9% uptime, and 9-12 month deployment supporting approximately 65,000 annual radiology studies. Collier County issued a Notice of Intent to single-source ultrasound equipment (KOSMOS platform with TORSO-ONE USB probe) from EchoNous, Inc., with contract term from March 26, 2026, to March 25, 2028. The Albuquerque Police Department posted an RFB for on-call phlebotomy technician services due February 25, 2026, with anticipated volume of 300 annual blood draw calls and a three-year initial term renewable for up to two additional one-year periods. The code shows limited relevant recent activity; firms evaluating this code should verify issuing-body tagging before resource commitment.